As of this writing, the FDA has approved 40 novel drugs so far this year compared to just 27 during the same period (Jan-Sep) last year. Now, let's take a look at the biotech stocks facing FDA decision in October.
from RTT - Biotech https://ift.tt/30avolk
via IFTTT
No comments:
Post a Comment